Article
An efficient tool for surveying CRF01_AE HIV type 1 resistance in Thailand to combined stavudine-lamivudine-nevirapine treatment: mutagenically separated PCR targeting M184I/V.
AIDS research and human retroviruses - 1 Dec 2007
Saeng-Aroon Siriphan, Yoshida Lay Myint, Ariyoshi Koya, Taguchi Masataka, Pathipvanich Panita, Rojanawiwat Archawin, Matsuda Masakazu, Kannagi Mari, Sawanpanyalert Pathom, Sugiura Wataru, Auwanit Wattana
Abstract excerpt
Under programs organized by the government of Thailand, HIV-1-infected patients have been treated since 2002 with several regimens, including a tablet known as GPOvir, which contains lamivudine, stavudine, and nevirapine. The aim of this study was to establish an effective assay, based on mutagen...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.